Related Experiment Video
Updated: Aug 29, 2025

A Multicenter MRI Protocol for the Evaluation and Quantification of Deep Vein Thrombosis
Published on: June 2, 2015
Diagnosis and treatment of thrombotic microangiopathy
Gemma L Thompson1,2, David Kavanagh1,2
1Complement Therapeutics Research Group, Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, UK.
Abstract:
Thrombotic microangiopathy (TMA) is characterized by thrombocytopenia, microangiopathic haemolytic anaemia and end organ damage. TMAs have varying underlying pathophysiology and can therefore present with an array of clinical presentations. Renal involvement is common as the kidney is particularly susceptible to the endothelial damage and microvascular occlusion. TMAs require rapid assessment, diagnosis, and commencement of appropriate treatment due to the high morbidity and mortality associated with them. Ground-breaking research into the pathogenesis of TMAs over the past 20 years has driven the successful development of targeted therapeutics revolutionizing patient outcomes. This review outlines the clinical presentations, pathogenesis, diagnostic tests and treatments for TMAs.
Insights
Thrombotic microangiopathy (TMA) involves low platelets, red blood cell destruction, and organ damage. Recent research has led to targeted treatments, improving outcomes for this serious condition.
Area of Science:
- Hematology
- Nephrology
- Pathophysiology
Background:
- Thrombotic microangiopathy (TMA) presents with thrombocytopenia, microangiopathic hemolytic anemia, and end-organ damage.
- Kidney involvement is frequent due to susceptibility to endothelial damage and microvascular occlusion.
- TMAs necessitate prompt evaluation, diagnosis, and treatment due to high morbidity and mortality.
Purpose of the Study:
- To review the clinical presentations of TMAs.
- To discuss the underlying pathogenesis of TMAs.
- To outline diagnostic tests and treatments for TMAs.
Main Methods:
- Literature review of thrombotic microangiopathy.
- Synthesis of recent advancements in TMA pathogenesis.
- Compilation of diagnostic and therapeutic strategies for TMAs.
Main Results:
- TMAs exhibit diverse clinical presentations based on underlying pathophysiology.
- Advances in understanding TMA pathogenesis have enabled targeted therapies.
- Effective management relies on timely diagnosis and appropriate treatment initiation.
Conclusions:
- This review provides a comprehensive overview of TMAs.
- Understanding TMA pathophysiology is key to developing effective treatments.
- Targeted therapeutics have significantly improved patient outcomes in TMAs.
More Related Videos
Related Concept Videos
Venous Thrombosis III: Interprofessional Care
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
Peripheral Artery Disease III: Interprofessional Care
Venous Thrombosis IV: Nursing Management
Anticoagulant Drugs: Low-Molecular-Weight Heparins

